Comparative Study between Febuxostat and Allupurinol based on Safety and Urate-Lowering Efficacy in Gout Patients of Indian Population

نویسندگان

  • Shikhar Tyagi
  • Shalini Rawat
  • Sarika Saxena
چکیده

Gout is a form of arthritis with a documented history spanning several thousands of years. Observed by the ancient Egyptian medical practitioner Imhotep as early as 2640BCE, it was also described several centuries later by the Greek physician Hippocrates (400BCE), the father of modern medicine, who referred to it as podagra, or “the unwalkable disease”. Gout represents the most frequent inflammatory joint disease in the general population 1, and it largely contributes to healthcare burden (Smith et al., 2014). Monosodium urate deposition due to longstanding hyperuricemia leading to urate crystal formation in tissues represents the International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 10 (2016) pp. 801-815 Journal homepage: http://www.ijcmas.com

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age

BACKGROUND The incidence of gout rises with increasing age. Management of elderly (≥65 years) gout patients can be challenging due to high rates of comorbidities, such as renal impairment and cardiovascular disease, and concomitant medication use. However, there is little data specifically addressing the efficacy and safety of available urate-lowering therapies (ULT) in the elderly. The objecti...

متن کامل

Diabetes and gout: efficacy and safety of febuxostat and allopurinol

AIM Assess influences of demographics and co-morbidities of gout patients with or without diabetes on safety and efficacy of urate-lowering agents. METHODS Post-hoc analysis of 312 diabetic and 1957 non-diabetic gout patients [baseline serum urate levels (sUA) ≥8.0 mg/dl] enrolled in a 6-month randomized controlled trial comparing urate-lowering efficacy (ULE) and safety of daily xanthine oxi...

متن کامل

Comparative efficacy and safety of urate-lowering therapy for the treatment of hyperuricemia: a systematic review and network meta-analysis

The prevalence of hyperuricemia and gout has been increasing, but the comparative effectiveness and safety of different treatments remain uncertain. We aimed to compare the effectiveness and safety of different treatments for hyperuricemia using network meta-analysis methodology. We systematically reviewed fifteen randomized controlled trials (involving 7,246 patients through January 2016) that...

متن کامل

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.

OBJECTIVES This 5-yr study assessed urate-lowering and clinical efficacy and safety of long-term febuxostat therapy in subjects with gout. The primary efficacy end-point was reduction to and maintenance of serum urate (sUA) levels < 6.0 mg/dl. METHODS Subjects who completed a previous 28-day study were entered into an open-label extension study and initially received febuxostat 80 mg daily. B...

متن کامل

Urate Lowering Therapy with Febuxostat in Daily Practice—A Multicentre, Open-Label, Prospective Observational Study

Introduction. Febuxostat, a novel xanthine oxidase inhibitor for the treatment of symptomatic hyperuricemia, showed superiority over allopurinol in the reduction of serum uric acid levels in pivotal studies. Whether this holds true the FORTE (febuxostat in the oral urate lowering treatment: effectiveness and safety) study was conducted to evaluate treatment with febuxostat under daily practice ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2016